S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
Log in

NASDAQ:AMPE - Ampio Pharmaceuticals Stock Price, Forecast & News

$0.62
-0.03 (-4.60 %)
(As of 02/24/2020 11:14 AM ET)
Today's Range
$0.60
Now: $0.62
$0.65
50-Day Range
$0.58
MA: $0.67
$0.73
52-Week Range
$0.26
Now: $0.62
$1.31
Volume384,218 shs
Average Volume1.28 million shs
Market Capitalization$98.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AMPE
CUSIPN/A
CIKN/A
Phone720-437-6500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees22
Market Cap$98.79 million
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.


Ampio Pharmaceuticals (NASDAQ:AMPE) Frequently Asked Questions

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the NASDAQ under the ticker symbol "AMPE."

When is Ampio Pharmaceuticals' next earnings date?

Ampio Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Ampio Pharmaceuticals.

What is the consensus analysts' recommendation for Ampio Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ampio Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ampio Pharmaceuticals.

Has Ampio Pharmaceuticals been receiving favorable news coverage?

Press coverage about AMPE stock has trended negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Ampio Pharmaceuticals earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the stock's share price in the near term. View News Stories for Ampio Pharmaceuticals.

Who are some of Ampio Pharmaceuticals' key competitors?

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Strongbridge Biopharma (SBBP), Acasti Pharma (ACST), Agile Therapeutics (AGRX), Applied Genetic Technologies (AGTC), Chiasma (CHMA), Endo International (ENDP), Genocea Biosciences (GNCA), OncoCyte (OCX), Veru (VERU) and vTv Therapeutics (VTVT).

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the folowing people:
  • Mr. Michael E. Macaluso, Founder, Chairman & CEO (Age 67)
  • Ms. Holli Cherevka, Chief Operating Officer (Age 36)
  • Mr. Daniel G. Stokely, CFO & Corp. Sec. (Age 55)
  • Lane Hapke, VP of Manufacturing Operations
  • April Ramirez, Clinical Trial Mang.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $0.62.

How big of a company is Ampio Pharmaceuticals?

Ampio Pharmaceuticals has a market capitalization of $98.79 million. Ampio Pharmaceuticals employs 22 workers across the globe.View Additional Information About Ampio Pharmaceuticals.

What is Ampio Pharmaceuticals' official website?

The official website for Ampio Pharmaceuticals is http://www.ampiopharma.com/.

How can I contact Ampio Pharmaceuticals?

The company can be reached via phone at 720-437-6500.


MarketBeat Community Rating for Ampio Pharmaceuticals (NASDAQ AMPE)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  2 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Ampio Pharmaceuticals and other stocks. Vote "Outperform" if you believe AMPE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMPE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Featured Article: What is the Beige Book?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel